For episode 32, we chat with Nicolas Tilmans, Founder & CEO at Anagenex.  Stay tuned to learn how Anagenex is combining the power of machine learning and biochemistry to revolutionize the drug discovery process. First In Human is a biotech-focused podcast that interviews industry leaders and investors to learn about their journey to in-human clinical trials. Presented by Vial, a tech-enabled CRO, hosted by Simon Burns, CEO & Co-Founder & guest host Co-Founder, Andrew Brackin. Episodes launch weekly on Tuesdays. To view the full transcript of this episode, click here.Interested in being featured as a guest on First In Human? Please reach out to catie@vial.com.